Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
| Status: | Terminated |
|---|---|
| Conditions: | Depression, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 4/21/2016 |
| Start Date: | January 2010 |
| End Date: | February 2014 |
Adjunctive Lisdexamfetamine in Bipolar Depression
The specific aim of this study is to evaluate the efficacy and tolerability of a stimulant
(lisdexamfetamine) in the adjunctive treatment of bipolar disorder.
(lisdexamfetamine) in the adjunctive treatment of bipolar disorder.
Inclusion Criteria:
- Men and women, through the ages of 18 and 55 years, inclusive.
Exclusion Criteria:
- Women who are pregnant, lactating, or of childbearing potential who are not using
adequate contraceptive measures.
- Subjects who are displaying clinically significant homicidality or suicidality
- Clinically unstable medical disease, including cardiovascular, hepatic, renal,
gastrointestinal, pulmonary, metabolic, endocrine or other systemic disease. Subjects
should be biochemically euthyroid to enter the study.
We found this trial at
1
site
Click here to add this to my saved trials
